Filing Details

Accession Number:
0001140361-11-025178
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-05 14:52:40
Reporting Period:
2011-04-29
Filing Date:
2011-05-05
Accepted Time:
2011-05-05 14:52:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1221590 Jacques Jean Bienaime C/O Biomarin Pharmaceutical Inc.
105 Digital Drive
Novato CA 94949
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-04-29 1,826 $11.64 91,893 No 5 A Direct
Common Stock Acquisiton 2011-05-03 3,000 $9.86 94,893 No 4 M Direct
Common Stock Disposition 2011-05-03 3,000 $26.68 91,893 No 4 S Direct
Common Stock Disposition 2011-05-03 2,000 $27.11 89,893 No 4 S Direct
Common Stock Acquisiton 2011-05-04 1,000 $9.86 90,893 No 4 M Direct
Common Stock Disposition 2011-05-04 1,000 $25.84 89,893 No 4 S Direct
Common Stock Disposition 2011-05-04 1,700 $26.30 88,193 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 A Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2011-05-03 3,000 $0.00 3,000 $9.86
Common Stock Stock Option (right to buy) Disposition 2011-05-04 1,000 $0.00 1,000 $9.86
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,040,764 2005-11-11 2015-11-10 No 4 M Direct
2,039,764 2005-11-11 2015-11-10 No 4 M Direct
Footnotes
  1. The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 1, 2010 to April 29, 2011.
  2. The price in Column 4 is a weighted average price. The prices actually received ranged from $26.69 to $26.684. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. The price in Column 4 is a weighted average price. The prices actually received ranged from $25.891 to $26.35. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  4. Original option granted on November 11, 2005 and vests equally 1/3 each on May 11, 2006, May 11, 2007, and May 27, 2008.